1887

Journal of General Virology header logo

Volume 93, Issue 1

Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding Free

Abstract

The dengue virus (DENV) envelope (E) protein mediates virus entry into cells via interaction with a range of cell-surface receptor molecules. Cell-surface glycosaminoglycans (GAGs) have been shown to play an early role in this interaction, and charged oligosaccharides such as heparin bind to the E protein. We have examined this interaction using site-directed mutagenesis of a recombinant form of the putative receptor-binding domain III of the DENV-2E protein expressed as an MBP (maltose-binding protein)-fusion protein. Using an ELISA-based GAG-binding assay, cell-based binding analysis and antiviral-activity assays, we have identified two critical residues, K291 and K295, that are involved in GAG interactions. These studies have also demonstrated differential binding between mosquito and human cells.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.037317-0
2012-01-01
2023-06-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/1/72.html?itemId=/content/journal/jgv/10.1099/vir.0.037317-0&mimeType=html&fmt=ahah

References

  1. Abd-Jamil J., Cheah C. Y., AbuBakar S. 2008; Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites. Protein Eng Des Sel 21:605–611 [View Article][PubMed]
     [Google Scholar]
  2. Akhtar J., Shukla D. 2009; Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276:7228–7236 [View Article][PubMed]
     [Google Scholar]
  3. Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., Marks R. M. 1997; Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3:866–871 [View Article][PubMed]
     [Google Scholar]
  4. Chen H.-L., Her S.-Y., Huang K.-C., Cheng H.-T., Wu C.-W., Wu S.-C., Cheng J.-W. 2010; Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers 94:331–338 [View Article][PubMed]
     [Google Scholar]
  5. Chu J. J., Rajamanonmani R., Li J., Bhuvanakantham R., Lescar J., Ng M. L. 2005; Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86:405–412 [View Article][PubMed]
     [Google Scholar]
  6. de Witte L., Bobardt M., Chatterji U., Degeest G., David G., Geijtenbeek T. B. H., Gallay P. 2007; Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 104:19464–19469 [View Article][PubMed]
     [Google Scholar]
  7. Erb S. M., Butrapet S., Moss K. J., Luy B. E., Childers T., Calvert A. E., Silengo S. J., Roehrig J. T., Huang C. Y., Blair C. D. 2010; Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Virology 406:328–335 [View Article][PubMed]
     [Google Scholar]
  8. Fritz R., Stiasny K., Heinz F. X. 2008; Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183:353–361 [View Article][PubMed]
     [Google Scholar]
  9. Germi R., Crance J. M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R. W., Zarski J. P., Drouet E. 2002; Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292:162–168 [View Article][PubMed]
     [Google Scholar]
  10. Guirakhoo F., Heinz F. X., Kunz C. 1989; Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology 169:90–99 [View Article][PubMed]
     [Google Scholar]
  11. Hallak L. K., Kwilas S. A., Peeples M. E. 2007; Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol Biol 379:15–34 [View Article][PubMed]
     [Google Scholar]
  12. Hileman R. E., Fromm J. R., Weiler J. M., Linhardt R. J. 1998; Glycosaminoglycan–protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156–167 [View Article][PubMed]
     [Google Scholar]
  13. Hiramatsu K., Tadano M., Men R., Lai C. J. 1996; Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224:437–445 [View Article][PubMed]
     [Google Scholar]
  14. Huang K. C., Lee M. C., Wu C. W., Huang K. J., Lei H. Y., Cheng J. W. 2008; Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein. Proteins 70:1116–1119 [View Article][PubMed]
     [Google Scholar]
  15. Hung S. L., Lee P. L., Chen H. W., Chen L. K., Kao C. L., King C. C. 1999; Analysis of the steps involved in dengue virus entry into host cells. Virology 257:156–167 [View Article][PubMed]
     [Google Scholar]
  16. Hung J. J., Hsieh M. T., Young M. J., Kao C. L., King C. C., Chang W. 2004; An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78:378–388 [View Article][PubMed]
     [Google Scholar]
  17. Jindadamrongwech S., Thepparit C., Smith D. R. 2004; Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 149:915–927 [View Article][PubMed]
     [Google Scholar]
  18. Kampmann T., Mueller D. S., Mark A. E., Young P. R., Kobe B. 2006; The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 14:1481–1487 [View Article][PubMed]
     [Google Scholar]
  19. Kanai R., Kar K., Anthony K., Gould L. H., Ledizet M., Fikrig E., Marasco W. A., Koski R. A., Modis Y. 2006; Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80:11000–11008 [View Article][PubMed]
     [Google Scholar]
  20. Kroschewski H., Allison S. L., Heinz F. X., Mandl C. W. 2003; Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308:92–100 [View Article][PubMed]
     [Google Scholar]
  21. Kuhn R. J., Zhang W., Rossmann M. G., Pletnev S. V., Corver J., Lenches E., Jones C. T., Mukhopadhyay S., Chipman P. R., Strauss E. G. 2002; Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725 [View Article][PubMed]
     [Google Scholar]
  22. Lee E., Lobigs M. 2000; Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74:8867–8875 [View Article][PubMed]
     [Google Scholar]
  23. Lee E., Lobigs M. 2002; Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76:4901–4911 [View Article][PubMed]
     [Google Scholar]
  24. Lee E., Hall R. A., Lobigs M. 2004; Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78:8271–8280 [View Article][PubMed]
     [Google Scholar]
  25. Lee E., Wright P. J., Davidson A., Lobigs M. 2006; Virulence attenuation of dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. J Gen Virol 87:2791–2801 [View Article][PubMed]
     [Google Scholar]
  26. Liao M., Kielian M. 2005; Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J Cell Biol 171:111–120 [View Article][PubMed]
     [Google Scholar]
  27. Lin B., Parrish C. R., Murray J. M., Wright P. J. 1994; Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202:885–890 [View Article][PubMed]
     [Google Scholar]
  28. Mackenzie J. S., Gubler D. J., Petersen L. R. 2004; Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:Suppl.S98–S109 [View Article][PubMed]
     [Google Scholar]
  29. Miller J. L., de Wet B. J., Martinez-Pomares L., Radcliffe C. M., Dwek R. A., Rudd P. M., Gordon S. 2008; The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4:e17 [View Article][PubMed]
     [Google Scholar]
  30. Modis Y., Ogata S., Clements D., Harrison S. C. 2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991 [View Article][PubMed]
     [Google Scholar]
  31. Modis Y., Ogata S., Clements D., Harrison S. C. 2004; Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313–319 [View Article][PubMed]
     [Google Scholar]
  32. Modis Y., Ogata S., Clements D., Harrison S. C. 2005; Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79:1223–1231 [View Article][PubMed]
     [Google Scholar]
  33. Mueller D. S., Kampmann T., Yennamalli R., Young P. R., Kobe B., Mark A. E. 2008; Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans 36:43–45 [View Article][PubMed]
     [Google Scholar]
  34. Mukherjee M., Dutta K., White M. A., Cowburn D., Fox R. O. 2006; NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition. Protein Sci 15:1342–1355 [View Article][PubMed]
     [Google Scholar]
  35. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J. L., Arenzana-Seisdedos F., Desprès P. 2003; Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723–728 [View Article][PubMed]
     [Google Scholar]
  36. Nishioka S., Aikawa J., Ida M., Matsumoto I., Street M., Tsujimoto M., Kojima-Aikawa K. 2007; Ligand-binding activity and expression profile of annexins in Caenorhabditis elegans. J Biochem 141:47–55 [View Article][PubMed]
     [Google Scholar]
  37. Pokidysheva E., Zhang Y., Battisti A. J., Bator-Kelly C. M., Chipman P. R., Xiao C., Gregorio G. G., Hendrickson W. A., Kuhn R. J., Rossmann M. G. 2006; Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124:485–493 [View Article][PubMed]
     [Google Scholar]
  38. Putnak J. R., Kanesa-Thasan N., Innis B. L. 1997; A putative cellular receptor for dengue viruses. Nat Med 3:828–829 [View Article][PubMed]
     [Google Scholar]
  39. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. 1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298 [View Article][PubMed]
     [Google Scholar]
  40. Reyes-del Valle J., Chávez-Salinas S., Medina F., del Angel R. M. 2005; Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79:4557–4567 [View Article][PubMed]
     [Google Scholar]
  41. Roehrig J. T., Bolin R. A., Kelly R. G. 1998; Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317–328 [View Article][PubMed]
     [Google Scholar]
  42. Ruiz-Sáenz J., Goez Y., Tabares W., López-Herrera A. 2009; Cellular receptors for foot and mouth disease virus. Intervirology 52:201–212 [View Article][PubMed]
     [Google Scholar]
  43. Su C. M., Liao C. L., Lee Y. L., Lin Y. L. 2001; Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286:206–215 [View Article][PubMed]
     [Google Scholar]
  44. Tassaneetrithep B., Burgess T. H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M. A., Pattanapanyasat K., Sarasombath S.other authors 2003; DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197:823–829 [View Article][PubMed]
     [Google Scholar]
  45. Thaisomboonsuk B. K., Clayson E. T., Pantuwatana S., Vaughn D. W., Endy T. P. 2005; Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells. Am J Trop Med Hyg 72:375–383[PubMed]
     [Google Scholar]
  46. Thepparit C., Smith D. R. 2004; Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 78:12647–12656 [View Article][PubMed]
     [Google Scholar]
  47. Thullier P., Demangel C., Bedouelle H., Mégret F., Jouan A., Deubel V., Mazié J. C., Lafaye P. 2001; Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol 82:1885–1892[PubMed]
     [Google Scholar]
  48. Tio P. H., Jong W. W., Cardosa M. J. 2005; Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virol J 2:25 [View Article][PubMed]
     [Google Scholar]
  49. Upanan S., Kuadkitkan A., Smith D. R. 2008; Identification of dengue virus binding proteins using affinity chromatography. J Virol Methods 151:325–328 [View Article][PubMed]
     [Google Scholar]
  50. Vlasak M., Goesler I., Blaas D. 2005; Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 79:5963–5970 [View Article][PubMed]
     [Google Scholar]
  51. Volk D. E., Beasley D. W., Kallick D. A., Holbrook M. R., Barrett A. D., Gorenstein D. G. 2004; Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 279:38755–38761 [View Article][PubMed]
     [Google Scholar]
  52. Volk D. E., Chavez L., Beasley D. W., Barrett A. D., Holbrook M. R., Gorenstein D. G. 2006; Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology 351:188–195 [View Article][PubMed]
     [Google Scholar]
  53. Volk D. E., Lee Y. C., Li X., Thiviyanathan V., Gromowski G. D., Li L., Lamb A. R., Beasley D. W., Barrett A. D., Gorenstein D. G. 2007; Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364:147–154 [View Article][PubMed]
     [Google Scholar]
  54. WHO 2009 Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control Geneva, Switzerland: World Health Organization;
     [Google Scholar]
  55. Wu K. P., Wu C. W., Tsao Y. P., Kuo T. W., Lou Y. C., Lin C. W., Wu S. C., Cheng J. W. 2003; Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 278:46007–46013 [View Article][PubMed]
     [Google Scholar]
  56. Wu C. W., Lin Y. T., Huang K. C., Cheng J. W. 2005; 1H, 15N and 13C resonance assignments of the domain III of the dengue virus envelope protein. J Biomol NMR 33:76 [View Article][PubMed]
     [Google Scholar]
  57. Yu S., Wuu A., Basu R., Holbrook M. R., Barrett A. D. T., Lee J. C. 2004; Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses. Biochemistry 43:9168–9176 [View Article][PubMed]
     [Google Scholar]
  58. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J. H., Baker T. S., Kuhn R. J., Rossmann M. G. 2004; Conformational changes of the flavivirus E glycoprotein. Structure 12:1607–1618 [View Article][PubMed]
     [Google Scholar]
  59. Zhang J. L., Wang J. L., Gao N., Chen Z. T., Tian Y. P., An J. 2007; Up-regulated expression of beta3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells. Biochem Biophys Res Commun 356:763–768 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.037317-0
Loading
Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding
J. Gen. Virol. 93, 72 (2012); https://doi.org/10.1099/vir.0.037317-0
/content/journal/jgv/10.1099/vir.0.037317-0
/content/journal/jgv/10.1099/vir.0.037317-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error